You are here

  • Home
  • Archive
  • Volume 81, Issue 1
  • Response to: ‘Polyfunctional TEM cells in psoriatic arthritis synovium skewed towards Th17 cells’ by Raychaudhuri et al

Article info

Article menu

Download PDFPDF

Correspondence response
Response to: ‘Polyfunctional TEM cells in psoriatic arthritis synovium skewed towards Th17 cells’ by Raychaudhuri et al

Authors

  • Mary Canavan Molecular Rheumatology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland EULAR Centre of Excellence For Arthritis And Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Sarah M Wade Molecular Rheumatology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Douglas J Veale EULAR Centre of Excellence For Arthritis And Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Ursula Fearon Molecular Rheumatology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland EULAR Centre of Excellence For Arthritis And Rheumatic Diseases, St. Vincent's University Hospital, Dublin, Ireland PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Douglas J Veale, EULAR Centre For Arthritis And Rheumatic Diseases, University College Dublin, Dublin 4, Ireland; douglas.veale{at}ucd.ie
View Full Text

Citation

Canavan M, Wade SM, Veale DJ, et al
Response to: ‘Polyfunctional TEM cells in psoriatic arthritis synovium skewed towards Th17 cells’ by Raychaudhuri et al
Annals of the Rheumatic Diseases 2022;81:e6.

Publication history

  • Received December 19, 2019
  • Revised December 20, 2019
  • Accepted December 23, 2019
  • First published January 8, 2020.
Online issue publication 
January 04, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.